ReviewTherapeutic advances in endocrinology and metabolism2018

A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products.

Wesley Nuffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.